# Desflurane

## Suprane 240mL

| 藥物代碼           | ESUP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Inhalation agent for induction & maintenance of general anesth.                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 副作用             | Dose-dependent hypotension & respiratory depression. Cough, breath holding, salivation, apnoea & laryngospasm. Post-op nausea & vomiting. Transient increase of WBC count, malignant hyperthermia.                                                                                                                                                                                                                                                                                                              |
| 禁忌               | Patient in whom general anaesth is contraindicated. Sensitivity to halogenated agents. Genetic susceptibility to malignant hyperthermia.                                                                                                                                                                                                                                                                                                                                                                        |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 用法用量           | Induction: Adult Initially 3%, increased by 0.5-1% every 2-3 breaths. Inspired concentration of 4-11% produces surgical anesth in 2-4 mins. Maintenance: Adult 2-6% with nitrous oxide, 2.5-8.5% with oxygen enriched air. Children 5.2-10%.                                                                                                                                                                                                                                                                    |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 懷孕用藥危分級     | 可能安全                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 注射劑給藥建議途徑 | IH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 注意事項           | 1.Suprane (desflurane) should be administered only by persons trained in the administration of general anesthesia. It should only be administered using a vaporizer specifically designed and designated for use with Suprane. 2.The administration of general anesthesia must be individualized based on the patient’s response, including cardiovascular and pulmonary changes. 3.Suprane (desflurane) should not be used as the sole agent for anesthetic induction in patients with coronary artery disease |

